Munich Re's Buyback Tally Rises as Analyst Divergence Widens Ahead of Full Results
Published on 07/26/2026 at 12:52 | Redaktion boerse-global.de
The world's largest reinsurer delivered a second-quarter net profit of roughly €2.2 billion, crushing the consensus estimate of €1.786 billion by more than 23 percent. Yet the market's response has been anything but a clean vote of confidence. Munich Re shares closed Friday at €508.80, up 0.79 percent on the day, but the subdued move masks a deepening split among analysts over what comes next.
The outperformance stemmed from two familiar drivers: an unusually low burden from major claims in the property and casualty reinsurance segment and a strong investment income result. The first-half group result of around €3.9 billion already exceeds half of the full-year target of €6.3 billion, which management reaffirmed alongside the preliminary numbers. The primary insurance subsidiary ERGO contributed a solid €0.3 billion to the group total, reinforcing its role as a stabilizing earnings pillar.
But the headline strength has been shadowed by a note of caution from the CFO. Andrew Buchanan told the Börsen-Zeitung that the company would closely examine its business pipeline for the second half — language that sparked market chatter about a possible guidance revision in the core reinsurance business. The group has explicitly confirmed the €6.3 billion target, yet the uncertainty has been enough to keep some analysts on the sidelines.
Should investors sell immediately? Or is it worth buying Münchener Rück?
RBC Capital Markets analyst Ben Cohen maintained his "Sector Perform" rating on Friday with a €490 price target, a level below the current share price. Despite the clear earnings beat, Cohen pointed to ongoing pricing pressure in the reinsurance market as reason for restraint. The DZ Bank, by contrast, reaffirmed its buy recommendation, arguing that the strong preliminary figures justify a more optimistic stance.
The stock now trades 5.79 percent above its 50-day moving average of €480.96 but remains 2.51 percent below the 200-day line of €521.90. The relative strength index of 59.3 sits in neutral territory, suggesting the shares are neither overbought nor oversold. Over the past 30 trading days, the stock has gained 5.91 percent, reflecting a gradual recovery from the year-to-date decline of 9.50 percent that still leaves Munich Re trailing the broader market.
Meanwhile, the buyback program for 2026/2027 continues without interruption. Between July 9 and July 17, Munich Re repurchased another 63,149 shares on Xetra, bringing the total since the program's launch on April 29 to 1,265,451 shares. The steady pace of repurchases typically provides a floor under the stock and signals management's conviction that the shares are undervalued.
All eyes now turn to August 7, when the full half-year financial report for the period ending June 30 is due. The complete quarterly figures will either confirm the strength of the preliminary release and dispel concerns about the casualty reinsurance outlook — vindicating the DZ Bank's bullish stance — or they will leave the guidance uncertainty unresolved, lending weight to RBC's more cautious view. The next regular quarterly update for the period ending September 30 is scheduled for November 12.
Ad
Münchener Rück Stock: New Analysis - 26 July
Fresh Münchener Rück information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
